Authors : Peng HY; Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.; Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China.

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/epidemiology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/complications ; Metabolic Diseases*/Metabolic Diseases*/Metabolic Diseases*/epidemiology

Source: BMC gastroenterology [BMC Gastroenterol] 2025 May 14; Vol. 25 (1), pp. 372. Date of Electronic Publication: 2025 May 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Identification of potential metabolic biomarkers and immune cell infiltration for metabolic associated steatohepatitis by bioinformatics analysis and machine learning.

Authors : Xie H; Hepatobiliary Pancreatic Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.; Wang J

Subjects: Machine Learning* ; Computational Biology*/Computational Biology*/Computational Biology*/methods ; Biomarkers*/Biomarkers*/Biomarkers*/metabolism

Source: Scientific reports [Sci Rep] 2025 May 13; Vol. 15 (1), pp. 16596. Date of Electronic Publication: 2025 May 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The association between total, animal, and plant protein intake and metabolic dysfunction-associated fatty liver disease in overweight and obese children and adolescents.

Authors : Nikparast A; Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Sohouli MH

Subjects: Pediatric Obesity*/Pediatric Obesity*/Pediatric Obesity*/complications ; Dietary Proteins*/Dietary Proteins*/Dietary Proteins*/administration & dosage ; Overweight*/Overweight*/Overweight*/complications

Source: Nutrition journal [Nutr J] 2025 May 10; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2025 May 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101152213 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2891

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions.

Authors : Jiménez-González C; Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, 39011 Santander, Spain.; Alonso-Peña M

Subjects: Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/physiology ; Artificial Intelligence* ; Life Style*

Source: Nutrients [Nutrients] 2025 May 04; Vol. 17 (9). Date of Electronic Publication: 2025 May 04.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Authors : Heo YJ; Institute of Medical Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea.; Park J

Subjects: Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects ; Glucosides*/Glucosides*/Glucosides*/pharmacology ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Apr 25; Vol. 26 (9). Date of Electronic Publication: 2025 Apr 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Targeting Metabolism: Innovative Therapies for MASLD Unveiled.

Authors : Wang W; Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.; Gao X

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/metabolism ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Fatty Liver*/Fatty Liver*/Fatty Liver*/metabolism

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Apr 25; Vol. 26 (9). Date of Electronic Publication: 2025 Apr 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway.

Authors : Taweesap P; Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Potue P

Subjects: Luteolin*/Luteolin*/Luteolin*/pharmacology ; Luteolin*/Luteolin*/Luteolin*/therapeutic use ; PPAR gamma*/PPAR gamma*/PPAR gamma*/metabolism

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Apr 17; Vol. 26 (8). Date of Electronic Publication: 2025 Apr 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Integrative transcriptomic and metabolomic analysis explores the mechanisms by which ACT001 treats MAFLD in mice.

Authors : Liu J; Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin, China.; Department of Hepatology, Tianjin Second People's Hospital, Tianjin, 300192, China.

Subjects: Metabolomics*/Metabolomics*/Metabolomics*/methods ; Transcriptome* ; Fatty Liver*/Fatty Liver*/Fatty Liver*/drug therapy

Source: Scientific reports [Sci Rep] 2025 Apr 11; Vol. 15 (1), pp. 12494. Date of Electronic Publication: 2025 Apr 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health.

Authors : Emanuele F; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties 'G. D'Alessandro' (PROMISE), Section of Endocrinology, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy.; Biondo M

Subjects: Diet, Ketogenic*/Diet, Ketogenic*/Diet, Ketogenic*/methods ; Diet, Ketogenic*/Diet, Ketogenic*/Diet, Ketogenic*/adverse effects ; Liver*/Liver*/Liver*/metabolism

Source: Nutrients [Nutrients] 2025 Apr 04; Vol. 17 (7). Date of Electronic Publication: 2025 Apr 04.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.

Authors : Song Z; Health Management Center, The Second Hospital of Dalian Medical University, No.467, Zhongshan Road, Dalian, 116023, China.; Department of Gastroenterology, The Second Hospital of Dalian Medical University, Dalian, 116023, Liaoning, China.

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/epidemiology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/diagnosis ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/blood

Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Apr 03; Vol. 24 (1), pp. 154. Date of Electronic Publication: 2025 Apr 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Clinical characteristics of MASLD/MetALD/MAFLD/NAFLD and the relative risk analysis on metabolic disorders.

Identification of potential metabolic biomarkers and immune cell infiltration for metabolic associated steatohepatitis by bioinformatics analysis and machine learning.

The association between total, animal, and plant protein intake and metabolic dysfunction-associated fatty liver disease in overweight and obese children and adolescents.

Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions.

Empagliflozin Alleviates Hepatic Steatosis and Oxidative Stress via the NRF1 Pathway in High-Fat Diet-Induced Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Targeting Metabolism: Innovative Therapies for MASLD Unveiled.

Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway.

Integrative transcriptomic and metabolomic analysis explores the mechanisms by which ACT001 treats MAFLD in mice.

Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health.

Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.

اتصل بنا

اتبع